Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT?

Involved site lymphoma radiotherapy clinical target volumes (CTV) require expansion in the absence of treatment-position pre-chemotherapy PET-CT. This prospective imaging study evaluates CTV contouring for axillary lymphoma using diagnostic imaging compared with co-registered treatment-position PET-...

Descripción completa

Detalles Bibliográficos
Autores principales: Prestwich, Robin, Patel, Chirag, Scarsbrook, Andrew, Cosgrove, Viv, Thomas, Emma, Gilson, Di, Bird, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146559/
https://www.ncbi.nlm.nih.gov/pubmed/30246160
http://dx.doi.org/10.1016/j.ctro.2018.09.003
_version_ 1783356419518496768
author Prestwich, Robin
Patel, Chirag
Scarsbrook, Andrew
Cosgrove, Viv
Thomas, Emma
Gilson, Di
Bird, David
author_facet Prestwich, Robin
Patel, Chirag
Scarsbrook, Andrew
Cosgrove, Viv
Thomas, Emma
Gilson, Di
Bird, David
author_sort Prestwich, Robin
collection PubMed
description Involved site lymphoma radiotherapy clinical target volumes (CTV) require expansion in the absence of treatment-position pre-chemotherapy PET-CT. This prospective imaging study evaluates CTV contouring for axillary lymphoma using diagnostic imaging compared with co-registered treatment-position PET-CT. Generous expansion axially and cranio-caudally is required to encompass pre-chemotherapy disease without treatment-position pre-chemotherapy PET-CT.
format Online
Article
Text
id pubmed-6146559
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61465592018-09-21 Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT? Prestwich, Robin Patel, Chirag Scarsbrook, Andrew Cosgrove, Viv Thomas, Emma Gilson, Di Bird, David Clin Transl Radiat Oncol Article Involved site lymphoma radiotherapy clinical target volumes (CTV) require expansion in the absence of treatment-position pre-chemotherapy PET-CT. This prospective imaging study evaluates CTV contouring for axillary lymphoma using diagnostic imaging compared with co-registered treatment-position PET-CT. Generous expansion axially and cranio-caudally is required to encompass pre-chemotherapy disease without treatment-position pre-chemotherapy PET-CT. Elsevier 2018-09-06 /pmc/articles/PMC6146559/ /pubmed/30246160 http://dx.doi.org/10.1016/j.ctro.2018.09.003 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Prestwich, Robin
Patel, Chirag
Scarsbrook, Andrew
Cosgrove, Viv
Thomas, Emma
Gilson, Di
Bird, David
Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT?
title Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT?
title_full Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT?
title_fullStr Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT?
title_full_unstemmed Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT?
title_short Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT?
title_sort axillary radiotherapy for nodal lymphoma: what ctv expansion is required to account for absence of pre-chemotherapy treatment position fdg pet-ct?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146559/
https://www.ncbi.nlm.nih.gov/pubmed/30246160
http://dx.doi.org/10.1016/j.ctro.2018.09.003
work_keys_str_mv AT prestwichrobin axillaryradiotherapyfornodallymphomawhatctvexpansionisrequiredtoaccountforabsenceofprechemotherapytreatmentpositionfdgpetct
AT patelchirag axillaryradiotherapyfornodallymphomawhatctvexpansionisrequiredtoaccountforabsenceofprechemotherapytreatmentpositionfdgpetct
AT scarsbrookandrew axillaryradiotherapyfornodallymphomawhatctvexpansionisrequiredtoaccountforabsenceofprechemotherapytreatmentpositionfdgpetct
AT cosgroveviv axillaryradiotherapyfornodallymphomawhatctvexpansionisrequiredtoaccountforabsenceofprechemotherapytreatmentpositionfdgpetct
AT thomasemma axillaryradiotherapyfornodallymphomawhatctvexpansionisrequiredtoaccountforabsenceofprechemotherapytreatmentpositionfdgpetct
AT gilsondi axillaryradiotherapyfornodallymphomawhatctvexpansionisrequiredtoaccountforabsenceofprechemotherapytreatmentpositionfdgpetct
AT birddavid axillaryradiotherapyfornodallymphomawhatctvexpansionisrequiredtoaccountforabsenceofprechemotherapytreatmentpositionfdgpetct

Ejemplares similares